Head of Lower Extremities Trauma Unit, Orthopaedic and Traumatology Service, Hospital Clínico Mutual de Seguridad, Avenida Libertador Bernardo O´Higgins 4848, Santiago, 9190015, Chile; University of Chile Clinical Hospital, Orthopaedic Surgery Service Attending, Avenida Dr. Carlos Lorca Tobar 999, Santiago, 8380456, Chile.
Orthopaedic and Traumatology Resident, Medical School, University of Chile, Postgraduate School. Avenida Dr. Carlos Lorca Tobar 999, Santiago, 8380456, Chile.
Injury. 2023 Nov;54 Suppl 6:110836. doi: 10.1016/j.injury.2023.05.067.
Fracture-related infection (FRI) is a common complication following open tibia fracture (OTF), especially in patients with high-energy trauma or comorbidities. The use of gentamicin-coated nail (GCN) has been proposed as a local adjuvant to prevent FRI in high-risk patients.
The incidence of FRI is expected to be lower in OTF treated with a GCN, alongside with no detrimental effects on fracture healing time.
This study aimed to evaluate the effectiveness of GCNs as a definitive fixation method and prophylaxis for FRI in OTFs. Secondary outcomes included non-union rates and time to healing.
The study design was a mixed cohort, including a prospective group of patients treated with GCN (Expert Tibial Nail PROtect™, Depuy Synthes, Johnson&Johnson Company Inc, New Jersey, USA) and a retrospectively evaluated group treated with non-gentamicin-coated nail (NGCN). Patients with at least 12 months of follow-up were included. The treatment protocol consisted of timely administration of antibiotics, surgical debridement, and early soft-tissue coverage. Exclusion criteria included protocol infringement, traumatic amputation, and loss of follow-up. Statistical analysis was performed using Stata v14.0, with a significance level of p < 0.05.
The study included 243 patients, 104 in GCN group and 139 NGCN group. External Fixator use was higher in the NGCN group, but this did not significantly affect the FRI rate. GCN use was associated with a significantly lower incidence of FRI (2.88% GCN group vs. 15.83% NGCN group, OR 0.16, p < 0.01). Furthermore, GCN use was found to be a protective factor against tibial non-union (OR 0.41, p = 0.03). There were no adverse effects attributed to locally administered gentamycin. The NGCN cohort had a higher incidence of polytrauma, although the difference was not statistically significant. A longer time to heal as well as more FRI and Non-union according to the progression in Gustilo-Anderson classification was observed in the GCN group.
Our findings suggest that GCN is an effective prophylactic method to reduce the risk of FRI in open tibial fractures at 12-month follow-up, as well as, probably derived from this protective effect, leading to lower fracture consolidation times when compared with cases treated without GCN.
本研究旨在评估 GCN 作为开放性胫骨骨折(OTF)确定性固定方法和 FRI 预防的有效性。次要结果包括非愈合率和愈合时间。
研究设计为混合队列,包括前瞻性 GCN 治疗组(Expert Tibial Nail PROtectTM,Depuy Synthes,Johnson&Johnson Company Inc,新泽西州,美国)和回顾性非庆大霉素涂层钉(NGCN)治疗组。纳入至少 12 个月随访的患者。治疗方案包括及时使用抗生素、手术清创和早期软组织覆盖。排除标准包括违反方案、创伤性截肢和失访。统计分析采用 Stata v14.0,显著性水平 p<0.05。
研究共纳入 243 例患者,GCN 组 104 例,NGCN 组 139 例。NGCN 组外固定器使用率较高,但对 FRI 发生率无显著影响。GCN 使用率与 FRI 发生率显著降低相关(GCN 组 2.88%,NGCN 组 15.83%,OR 0.16,p<0.01)。此外,GCN 使用率是预防胫骨不愈合的保护因素(OR 0.41,p=0.03)。局部给予庆大霉素无不良反应。NGCN 组多发伤发生率较高,但差异无统计学意义。GCN 组愈合时间较长,Gustilo-Anderson 分类进展的 FRI 和非愈合发生率较高。
我们的研究结果表明,GCN 是一种有效的预防方法,可降低开放性胫骨骨折 12 个月随访时 FRI 的风险,并且可能由于这种保护作用,与未使用 GCN 治疗的病例相比,骨折愈合时间更短。